文献速递腹部泌尿生殖MR

可解释的MRI多模态融合模型预测局部进展期直肠癌新辅助放化疗后淋巴结转移的研发与验证:一项多中心研究

Development and validation of an interpretable MRI-based multimodal fusion model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter study.
PubMed 文献 · Abdom Radiol (NY) · 2026-03-09

该研究基于三个独立中心190例局部进展期直肠癌患者的治疗前MRI,整合深度学习影像组学特征与Node-RADS评分构建DLRN联合模型,用于预测新辅助放化疗后淋巴结转移。DLRN模型在训练集和两个外部验证集的AUC分别为0.941、0.923和0.843,均优于单独的DLR模型和Node-RADS模型;SHAP分析显示Node-RADS和深度学习特征是关键预测特征。

要点

  • DLRN联合模型在训练集AUC 0.941、外部验证集1 AUC 0.923、外部验证集2 AUC 0.843,均优于单独DLR和Node-RADS模型。
  • Node-RADS评分与深度学习特征被SHAP分析确定为最重要的预测特征。
  • 模型基于治疗前T2加权和扩散加权成像,可解释性框架可能增强临床可信度。

核心结论

  • 基于多参数MRI的DLRN模型对局部进展期直肠癌患者新辅助放化疗后淋巴结转移表现出有前景的预测能力,可解释性框架增强了模型指导直肠癌个体化决策的临床可信度。

研究设计与样本

  • 回顾性多中心研究,纳入来自三个独立中心的190例局部进展期直肠癌患者,基于治疗前T2加权和扩散加权成像提取深度学习与影像组学特征,由放射科医师使用Node-RADS系统对淋巴结评分,采用逻辑回归分类器构建DLRN联合模型,并以受试者工作特征分析评价模型性能。

诊断标准与关键数值

  • 训练集AUC:DLRN模型0.941,DLR模型0.864,Node-RADS模型0.852。
  • 外部验证集1 AUC:DLRN模型0.923,DLR模型0.810,Node-RADS模型0.765。
  • 外部验证集2 AUC:DLRN模型0.843,DLR模型0.817,Node-RADS模型0.801。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop an interpretable multimodal model that integrates pre-treatment Magnetic resonance imaging (MRI)-based deep learning radiomics (DLR) features with Node-RADS scores to predict Lymph node metastasis (LNM) in locally advanced rectal cancer (LARC) patients after neoadjuvant chemoradiotherapy (nCRT).

METHODS: In total, 190 LARC patients from three independent centers were retrospectively included. Deep learning and radiomics features were derived from T2-weighted and diffusion-weighted imaging sequences before treatment. Lymph nodes were scored by radiologists using the Node-RADS system. The DLR Node-RADS (DLRN) combined model was constructed using the logistic regression classifier, and receiver operating characteristic analysis was employed to evaluate model performance. Furthermore, feature contributions were clarified using the SHapley Additive exPlanations (SHAP) analysis method.

RESULTS: The DLRN joint model has superior performance in predicting LNM, and it outperforms the individual DLR model and the Node-RADS model in both the training and two external validation sets. For training set, the area under the curve (AUC) were 0.941 for the DLRN model, 0.864 for the DLR model, and 0.852 for the Node-RADS model. In external validation set 1, the AUCs were 0.923, 0.810, and 0.765, respectively; in external validation set 2, they were 0.843, 0.817, and 0.801. SHAP analysis determined that Node-RADS and DL features are among the most critical predictive features.

CONCLUSION: The DLRN model based on multiparameter MRI has demonstrated a promising predictive ability for evaluating the LNM of LARC patients after nCRT. The novel interpretable framework enhances the clinical credibility of the model in guiding personalized decisions for rectal cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yang Y, Zeng L, Zhu C, et al. Development and validation of an interpretable MRI-based multimodal fusion model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter study. Abdom Radiol (NY). 2026. PMID: 41801383. doi:10.1007/s00261-026-05391-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。